NEW YORK, June 16, 2015 /PRNewswire/ -- Pharmaceutical drug sales are sold through various channels such as retail, mail orders, clinics and hospitals. Retail channel generate sales followed by mail orders, and collectively account for more than 50% of the pharmaceutical drugs sales. Hospital however account for a smaller share of about 8.6% of the total sales. This report exclusively studies the market for pharmaceutical drugs that are sold or delivered to patients in hospital settings.  
Global hospital pharmaceutical drugs market is segmented according to major therapeutic areas, which include: cardiology, oncology, nephrology and urology, neurology, pain and infection. Market for these major therapeutic areas has been further assessed according to drug classes. Cardiology segment is further divided into diuretic drugs, calcium channel inhibitors, anti-cholinergic agents, anti-arrhythmic agents, anti-adrenergic agents, and others (ACE inhibitors, angiotensin receptor blockers, anticoagulants). Oncology segment is further segmented into immunomodulating agents, alkylating agents, anti-metabolites, hormonal agents, and miscellaneous drugs. Nephrology and urology segment is further divided into diuretic drugs, anti-hypertensive agents, phosphate binders, anti-cholinergic agents and 5-alpha-reductase inhibitors. Neurology segment is divided into anti-anxiety, anti-migraine, anti-depressant and anti-psychotic drugs. Market for pain management drugs has been divided into anti-convulsant drugs, anesthetics, nonsteroidal anti-inflammatory drugs (NSAID), opioids, and non-narcotic analgesic drugs. Similarly anti-infective drugs market has been segmented into anti-bacterial drugs, anti-viral drugs, anti-fungal drugs and anti-parasite drugs. The report also provides a detailed list of potential phase III candidates for each of the therapeutic areas.   
The market has been further studied from the point of view of major diseases in these therapeutic areas. Thus the cardiology market has been studied considering coronary heart diseases, stroke, high blood pressure (hypertension), heart failure and other cardiovascular diseases. Oncology drugs market has been studied for lung cancer, breast cancer, colorectal cancer, prostate cancer, and others. Nephrology and urology drugs market is studied for acute kidney failure, chronic kidney diseases, glomerular diseases, diabetes and other diseases. Neurology market has been studied for epilepsy, Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke and other diseases.   
Market for pain has been studied for neuropathic pain, fibromyalgia, osteoarthritis, rheumatoid arthritis, cancer pain and others. The infection market is studied for major infectious disease such as tuberculosis, pneumonia, hepatitis A, hepatitis B, Candida infections, fungal meningitis, shigellosis, amoebiasis and other infections. The report also provides insights for various branded and blockbuster drugs under various therapeutic drug class along with other details such as manufacturer, approval date and the patent expiry.   
Furthermore the global market for hospital pharmaceutical drugs has been segmented into major geographies including North America, Europe, Asia Pacific and Rest of the World. Each of the market segments and sub-segments have been analyzed on the basis of current and future market size for the period 2012 to 2020, in terms of revenue (USD million), considering 2012 and 2013 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2014 to 2020 along with the estimations of market size. The report also provides detailed Porter's five forces analysis of the hospital pharmaceutical drugs market.   
Based on in-depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. Moreover lucrative opportunities and relevant recommendations for sustainable growth in the market also have been suggested. A detailed event impact analysis considers regulatory approvals and patent expiry of major drugs in the hospital pharmaceutical market. Value chain analysis, market share analysis and market attractiveness analysis further provides a complete market understanding.  
Key players profiled in the report include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Novartis, and Pfizer, Inc.   
The Global Hospital Pharmaceuticals Market is segmented into the following categories:   
Cardiology  

Anti-Adrenergic Drugs  

Calcium Channel Blockers  

Diuretic Drugs  

Anti-Arrhythmic Drugs  

Others  

Oncology  

Alkylating Agents  

Anti-Metabolites  

Hormonal Agents  

Immunomodulating Agents  

Miscellaneous Drugs  

Nephrology and Urology  

Diuretic Agents  

Anti-Hypertensive Agents  

Phosphate Binders  

Anticholinergic Drugs  

5-Alpha Reductase Inhibitors  

Neurology  

Anti-Anxiety Agents  

Detail2Anti-Migraine Drugs  

Antidepressant Drugs  

Anti-Psychotic Drugs  

Pain  

Anticonvulsant Drugs  

Anesthetic Drugs  

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)  

Opioids  

Non-Narcotics Analgesic Drugs  

Infection  

Antibacterial Drugs  

Antiviral Drugs  

Antifungal Drugs  

Antiparasite Drugs  
Global Hospital Pharmaceuticals Market, by Major Indications  

Cardiology  

Coronary Heart Diseases  

Stroke  

High Blood Pressure  

Heart Failure  

Others  

Oncology  

Lung Cancer  

Breast Cancer  

Colorectal Cancer  

Prostate Cancer  

Others  

Nephrology and Urology  

Acute Kidney Failure  

Chronic Kidney Diseases  

Glomerular Diseases  

Diabetes  

Others  

Neurology  

Epilepsy  

Alzheimer;s Disease  

Parkinson;s Disease  

Multiple Sclerosis  

Others  

Pain  

Neuropathic Pain  

Fibromyalgia  

Osteoarthritis  

Rheumatoid Arthritis  

Cancer Pain  

Infection  

Detail1Tuberculosis  

Pneumonia  

Hepatitis A  

Hepatitis B  

Candida Infection  

Fungal Meningitis  

Shigellosis  

Amoebiasis  

Other  
Global Hospital Pharmaceuticals Market, by Geography  

North America  

Europe  

Asia Pacific  

Rest of the World (RoW)  
Read the full report: http://www.reportlinker.com/p02466850-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com

                  
        __________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001
      

                  To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hospital-pharmaceuticals-market-cardiology-oncology-nephrology--urology-neurology-pain-and-infection---global-industry-analysis-size-share-growth-trends-and-forecast-2014---2020-300100303.html

                  SOURCE  Reportlinker


                  
        
      

                  Copyright (C) 2015 PR Newswire. All rights reserved


    

                            
                            
                                  
      
      
      
      
      
      
      
      


                


            

...